Cargando…
Etiology of Autoimmune Islet Disease: Timing Is Everything
Life is about timing. —Carl Lewis The understanding of autoimmune type 1 diabetes is increasing, and examining etiology separate from pathogenesis has become crucial. The components to explain type 1 diabetes development have been known for some time. The strong association with HLA has been researc...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336011/ https://www.ncbi.nlm.nih.gov/pubmed/34155043 http://dx.doi.org/10.2337/dbi18-0034 |
_version_ | 1783733243461238784 |
---|---|
author | Lernmark, Åke |
author_facet | Lernmark, Åke |
author_sort | Lernmark, Åke |
collection | PubMed |
description | Life is about timing. —Carl Lewis The understanding of autoimmune type 1 diabetes is increasing, and examining etiology separate from pathogenesis has become crucial. The components to explain type 1 diabetes development have been known for some time. The strong association with HLA has been researched for nearly 50 years. Genome-wide association studies added another 60+ non-HLA genetic factors with minor contribution to risk. Insulitis has long been known to be present close to clinical diagnosis. T and B cells recognizing β-cell autoantigens are detectable prior to diagnosis and in newly diagnosed patients. Islet autoantibody tests against four major autoantigens have been standardized and used as biomarkers of islet autoimmunity. However, to clarify the etiology would require attention to time. Etiology may be defined as the cause of a disease (i.e., type 1 diabetes) or abnormal condition (i.e., islet autoimmunity). Timing is everything, as neither the prodrome of islet autoimmunity nor the clinical onset of type 1 diabetes tells us much about the etiology. Rather, the islet autoantibody that appears first and persists would mark the diagnosis of an autoimmune islet disease (AID). Events after the diagnosis of AID would represent the pathogenesis. Several islet autoantibodies without (stage 1) or with impaired glucose tolerance (stage 2) or with symptoms (stage 3) would define the pathogenesis culminating in clinical type 1 diabetes. Etiology would be about the timing of events that take place before the first-appearing islet autoantibody. |
format | Online Article Text |
id | pubmed-8336011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-83360112021-08-20 Etiology of Autoimmune Islet Disease: Timing Is Everything Lernmark, Åke Diabetes Perspectives in Diabetes Life is about timing. —Carl Lewis The understanding of autoimmune type 1 diabetes is increasing, and examining etiology separate from pathogenesis has become crucial. The components to explain type 1 diabetes development have been known for some time. The strong association with HLA has been researched for nearly 50 years. Genome-wide association studies added another 60+ non-HLA genetic factors with minor contribution to risk. Insulitis has long been known to be present close to clinical diagnosis. T and B cells recognizing β-cell autoantigens are detectable prior to diagnosis and in newly diagnosed patients. Islet autoantibody tests against four major autoantigens have been standardized and used as biomarkers of islet autoimmunity. However, to clarify the etiology would require attention to time. Etiology may be defined as the cause of a disease (i.e., type 1 diabetes) or abnormal condition (i.e., islet autoimmunity). Timing is everything, as neither the prodrome of islet autoimmunity nor the clinical onset of type 1 diabetes tells us much about the etiology. Rather, the islet autoantibody that appears first and persists would mark the diagnosis of an autoimmune islet disease (AID). Events after the diagnosis of AID would represent the pathogenesis. Several islet autoantibodies without (stage 1) or with impaired glucose tolerance (stage 2) or with symptoms (stage 3) would define the pathogenesis culminating in clinical type 1 diabetes. Etiology would be about the timing of events that take place before the first-appearing islet autoantibody. American Diabetes Association 2021-07 2021-07-28 /pmc/articles/PMC8336011/ /pubmed/34155043 http://dx.doi.org/10.2337/dbi18-0034 Text en © 2021 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
spellingShingle | Perspectives in Diabetes Lernmark, Åke Etiology of Autoimmune Islet Disease: Timing Is Everything |
title | Etiology of Autoimmune Islet Disease: Timing Is Everything |
title_full | Etiology of Autoimmune Islet Disease: Timing Is Everything |
title_fullStr | Etiology of Autoimmune Islet Disease: Timing Is Everything |
title_full_unstemmed | Etiology of Autoimmune Islet Disease: Timing Is Everything |
title_short | Etiology of Autoimmune Islet Disease: Timing Is Everything |
title_sort | etiology of autoimmune islet disease: timing is everything |
topic | Perspectives in Diabetes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336011/ https://www.ncbi.nlm.nih.gov/pubmed/34155043 http://dx.doi.org/10.2337/dbi18-0034 |
work_keys_str_mv | AT lernmarkake etiologyofautoimmuneisletdiseasetimingiseverything |